Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 9 (September)

1. Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence.
   Clin Psychol Rev, 28(7): 1188-205. [Abstract] [Full-text]
2. Personal and societal construction of illness among individuals with rapid-cycling bipolar disorder: a life-trajectory perspective.
   Am J Geriatr Psychiatry, 16(9): 718-26. [Abstract] [Full-text]
3. Replication of linkage with bipolar disorder on chromosome 16p in the Eastern Quebec population.
   Am J Med Genet B Neuropsychiatr Genet, 147(6): 737-44. [Abstract] [Full-text]
4. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder.
   Am J Med Genet B Neuropsychiatr Genet, 147(6): 914-7. [Abstract] [Full-text]
5. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: an association study.
   Am J Med Genet B Neuropsychiatr Genet, 147(6): 976-82. [Abstract] [Full-text]
6. The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis.
   Am J Med Genet B Neuropsychiatr Genet, 147(6): 686-9. [Abstract] [Full-text]
7. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.
   Int J Neuropsychopharmacol, 11(6): 851-76. [Abstract] [Full-text]
8. Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis.
   Am J Med Genet B Neuropsychiatr Genet, 147(6): 814-21. [Abstract] [Full-text]
9. Initial association of NR2E1 with bipolar disorder and identification of candidate mutations in bipolar disorder, schizophrenia, and aggression through resequencing.
   Am J Med Genet B Neuropsychiatr Genet, 147(6): 880-9. [Abstract] [Full-text]
10. Temperament and character dimensions in bipolar I disorder: a comparison to healthy controls.
    J Psychiatr Res, 42(13): 1131-6. [Abstract] [Full-text]
11. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    J Psychiatr Res, 42(13): 1068-75. [Abstract] [Full-text]
12. Quality of web-based information on bipolar disorder.
    J Affect Disord, 110(3): 265-9. [Abstract] [Full-text]
13. A simulated genetic structure for bipolar illness.
    Am J Med Genet B Neuropsychiatr Genet, 147(6): 952-6. [Abstract] [Full-text]
14. A searchable database of genetic evidence for psychiatric disorders.
    Am J Med Genet B Neuropsychiatr Genet, 147(6): 671-5. [Abstract] [Full-text]
15. Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.
    Brain Behav Immun, 22(7): 1103-7. [Abstract] [Full-text]
16. Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new.
    Curr Opin Genet Dev. [Abstract] [Full-text]
17. The impact of co-morbid alcohol use disorder in bipolar patients.
    Alcohol, 42(6): 451-7. [Abstract] [Full-text]
18. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    J Child Adolesc Psychopharmacol, 18(4): 327-36. [Abstract] [Full-text]
19. Neural bases of emotional processing in pediatric bipolar disorder.
    Expert Rev Neurother, 8(9): 1381-7. [Abstract] [Full-text]
20. Hospitalization for psychiatric illness among community-dwelling elderly persons in 1992 and 2002.
    Psychiatr Serv, 59(9): 1046-8. [Abstract] [Full-text]
21. Psychiatric rehospitalization among elderly persons in the United States.
    Psychiatr Serv, 59(9): 1038-45. [Abstract] [Full-text]
22. A review of potential cognitive and environmental risk markers in children of bipolar parents.
    Clin Psychol Rev, 28(7): 1083-95. [Abstract] [Full-text]
23. Amantadine-associated corneal edema potentially irreversible even after cessation of the medication.
    Ophthalmology, 115(9): 1540-4. [Abstract] [Full-text]
24. Variation in the purinergic P2RX(7) receptor gene and schizophrenia.
    Schizophr Res, 104(1): 146-52. [Abstract] [Full-text]
25. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
    Pharmacopsychiatry, 41(5): 182-9. [Abstract] [Full-text]
26. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial.
    Arch Gen Psychiatry, 65(9): 1053-61. [Abstract] [Full-text]
27. Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics.
    Arch Gen Psychiatry, 65(9): 1041-52. [Abstract] [Full-text]
28. Advancing paternal age and bipolar disorder.
    Arch Gen Psychiatry, 65(9): 1034-40. [Abstract] [Full-text]
29. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder.
    Arch Gen Psychiatry, 65(9): 1017-32. [Abstract] [Full-text]
30. The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome.
    Psychol Med, 38(10): 1505-14. [Abstract] [Full-text]
31. Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion.
    Psychopharmacology (Berl), 200(2): 187-95. [Abstract] [Full-text]
32. Significance of cigarette smoking among youths with bipolar disorder.
    Am J Addict, 17(5): 364-71. [Abstract] [Full-text]
33. Transdiagnostic emotion regulation processes in bipolar disorder and insomnia.
    Behav Res Ther, 46(9): 1096-100. [Abstract] [Full-text]
34. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder.
    Psychiatry Res, 160(3): 285-99. [Abstract] [Full-text]
35. The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.
    Child Adolesc Psychiatry Ment Health, 2(1): 21. [Abstract] [Full-text]
36. Quality of life, anxiety and depression in Sarcoidosis.
    Gen Hosp Psychiatry, 30(5): 441-5. [Abstract] [Full-text]
37. Event related oscillations in euthymic patients with bipolar disorder.
    Neurosci Lett, 444(1): 5-10. [Abstract] [Full-text]
38. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
    Proc Natl Acad Sci U S A, 105(36): 13614-9. [Abstract] [Full-text]
39. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
    Pharmacogenomics, 9(9): 1353-8. [Abstract] [Full-text]
40. Pediatric bipolar disorder: recognition in primary care.
    Curr Opin Pediatr, 20(5): 560-5. [Abstract] [Full-text]
41. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders.
    J Gen Intern Med, 23(10): 1628-33. [Abstract] [Full-text]
42. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder.
    Neuropsychopharmacology, 33(11): 2551-65. [Abstract] [Full-text]
43. Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.
    Neurochem Res, 33(10): 1940-9. [Abstract] [Full-text]
44. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(7): 1637-42. [Abstract] [Full-text]
45. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(7): 1677-81. [Abstract] [Full-text]
46. Efficiency and safety of oxcarbazepine in mood disorders: A naturalistic study exploring the interest of plasma dosages.
    Eur Psychiatry, 23(6): 409-12. [Abstract] [Full-text]
47. Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability.
    Int J Methods Psychiatr Res. [Abstract] [Full-text]
48. Access to special care dentistry, part 6. Special care dentistry services for young people.
    Br Dent J, 205(5): 235-49. [Abstract] [Full-text]
49. Neurodevelopmental basis of bipolar disorder: a critical appraisal.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(7): 1617-27. [Abstract] [Full-text]
50. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    J Clin Psychopharmacol, 28(5): 555-60. [Abstract] [Full-text]
51. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    J Clin Psychopharmacol, 28(5): 509-17. [Abstract] [Full-text]
52. Investigation of the tryptophan hydroxylase 2 gene in bipolar I disorder in the Romanian population.
    Psychiatr Genet, 18(5): 240-7. [Abstract] [Full-text]
53. Abnormal corticostriatal activity during fear perception in bipolar disorder.
    Neuroreport, 19(15): 1523-7. [Abstract] [Full-text]
54. Olanzapine orally disintegrating tablet: a review of efficacy and compliance.
    CNS Neurosci Ther, 14(3): 203-14. [Abstract] [Full-text]
55. The collaborative care practice model in the long-term care of individuals with bipolar disorder: a case study.
    J Psychiatr Ment Health Nurs, 15(8): 649-53. [Abstract] [Full-text]
56. Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?
    Trends Neurosci, 31(10): 495-503. [Abstract] [Full-text]
57. Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review.
    Arch Psychiatr Nurs, 22(5): 305-11. [Abstract] [Full-text]
58. Coping styles of outpatients with a bipolar disorder.
    Arch Psychiatr Nurs, 22(5): 245-53. [Abstract] [Full-text]
59. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.
    Am J Med Genet B Neuropsychiatr Genet, 147(7): 1047-55. [Abstract] [Full-text]
60. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3).
    Am J Med Genet B Neuropsychiatr Genet, 147(7): 1182-5. [Abstract] [Full-text]
61. Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.
    Neurochem Res, 33(11): 2229-40. [Abstract] [Full-text]
62. Neurotransmission and bipolar disorder: a systematic family-based association study.
    Am J Med Genet B Neuropsychiatr Genet, 147(7): 1270-7. [Abstract] [Full-text]
63. Practical guidance for prescribing with aripiprazole in bipolar disorder.
    Curr Med Res Opin, 24(9): 2691-702. [Abstract] [Full-text]
64. Sexual risk behaviors and sexually transmitted infection prevalence in an outpatient psychiatry clinic.
    Sex Transm Dis, 35(10): 877-82. [Abstract] [Full-text]
65. Treatment of bipolar disorder: New perspectives.
    Ann Med. [Abstract] [Full-text]
66. The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness.
    Acta Psychiatr Scand, 118(4): 297-304. [Abstract] [Full-text]
67. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.
    Int J Neuropsychopharmacol, 11(7): 999-1029. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.